Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Froehlich

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Journal of Crohn'S & Colitis|May 14, 2013
When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panelValerie Pittet, Florian Froehlich, Michel H Maillard, et al.
Journal of Crohn'S & Colitis|January 28, 2014
Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitisMichel H Maillard, Murielle Bortolotti, John-Paul Vader, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel - EPACT IIChristian Felley, John-Paul Vader, Pascal Juillerat, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT IIChristian Mottet, John-Paul Vader, Christian Felley, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate maintenance treatment for Crohn's disease: Results of a multidisciplinary international expert panel - EPACT IIPascal Juillerat, John-Paul Vader, Christian Felley, et al.
Scandinavian Journal of Gastroenterology|July 27, 2010
Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohortPascal Juillerat, Valérie Pittet, Christian Mottet, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriateness of therapy for active Crohn's disease: Results of a multidisciplinary international expert panel-EPACT IIPierre Michetti, Marc Stelle, Pascal Juillerat, et al.
BMJ Open Gastroenterology|May 9, 2024
Population-level impact of the BMJ Rapid Recommendation for colorectal cancer screening: a microsimulation analysisLuuk A van Duuren, Jean-Luc Bulliard, Ella Mohr, et al.
JMIR Research Protocols|September 7, 2023
Colorectal Cancer Screening Decision Based on Predicted Risk: Protocol for a Pilot Randomized Controlled TrialEkaterina Plys, Jean-Luc Bulliard, Aziz Chaouch, et al.
The American Journal of Gastroenterology|January 8, 2025
Colorectal Cancer Screening Based on Predicted Risk: A Randomized Controlled TrialEkaterina Plys, Jean-Luc Bulliard, Aziz Chaouch, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Journal of Crohn'S & Colitis|May 14, 2013
When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panelValerie Pittet, Florian Froehlich, Michel H Maillard, et al.
Journal of Crohn'S & Colitis|January 28, 2014
Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitisMichel H Maillard, Murielle Bortolotti, John-Paul Vader, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel - EPACT IIChristian Felley, John-Paul Vader, Pascal Juillerat, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT IIChristian Mottet, John-Paul Vader, Christian Felley, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriate maintenance treatment for Crohn's disease: Results of a multidisciplinary international expert panel - EPACT IIPascal Juillerat, John-Paul Vader, Christian Felley, et al.
Scandinavian Journal of Gastroenterology|July 27, 2010
Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohortPascal Juillerat, Valérie Pittet, Christian Mottet, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Appropriateness of therapy for active Crohn's disease: Results of a multidisciplinary international expert panel-EPACT IIPierre Michetti, Marc Stelle, Pascal Juillerat, et al.
BMJ Open Gastroenterology|May 9, 2024
Population-level impact of the BMJ Rapid Recommendation for colorectal cancer screening: a microsimulation analysisLuuk A van Duuren, Jean-Luc Bulliard, Ella Mohr, et al.
JMIR Research Protocols|September 7, 2023
Colorectal Cancer Screening Decision Based on Predicted Risk: Protocol for a Pilot Randomized Controlled TrialEkaterina Plys, Jean-Luc Bulliard, Aziz Chaouch, et al.
The American Journal of Gastroenterology|January 8, 2025
Colorectal Cancer Screening Based on Predicted Risk: A Randomized Controlled TrialEkaterina Plys, Jean-Luc Bulliard, Aziz Chaouch, et al.
Pageof 7